Bioavailability of salbutamol

Lipworth, B J; Grove, A
November 1994
Thorax;Nov1994, Vol. 49 Issue 11, p1183
Academic Journal
No abstract available.


Related Articles

  • Design of Salbutamol Sulphate Gastroretentive Nanoparticles via Surface Charge Manipulation. Mudhakir, Diky; Fauzi Bostanudin, M.; Firmawan, Fiki; Mauludin, Rachmat // World Academy of Science, Engineering & Technology;2012, Issue 72, p71 

    In the present study, development of salbutamol sulphate nanoparticles that adhere to gastric mucus was investigated. Salbutamol sulphate has low bioavailability due to short transit time in gastric. It also has a positive surface charge that provides hurdles to be encapsulated by the positively...

  • Determination of the Relative Bioavailability of Salbutamol to the Lungs Following Inhalation from Dry Powder Inhaler Formulations Containing Drug Substance Manufactured by Supercritical Fluids and Micronization. Marcel de Matas; Harold Hosker; Rahul Mukherjee // Pharmaceutical Research;Nov2007, Vol. 24 Issue 11, p2008 

    Abstract Purpose  The relative lung bioavailability of salbutamol sulfate particles produced using supercritical fluids (SEDS™) and delivered by dry powder inhaler (DPI) was compared with the performance of a conventional micronized drug DPI using the same device...

  • FORMULATION AND EVALUATION OF THERMOSENSITIVE IN SITU GEL OF SALBUTAMOL SULPHATE FOR NASAL DRUG DELIVERY SYSTEM. Yadav, Dattatraya J.; Kunjwani, Harish K.; Suryawanshi, Sarika S. // International Journal of Pharmacy & Pharmaceutical Sciences;Oct2012 Supplement, Vol. 4, p188 

    This study aimed to formulate and evaluate Nasal drug delivery system containing Salbutamol Sulphate was prepared for improving the bioavailability & sustaining the drug release. Salbutamol sulphate is a selective β2 adrenoreceptor agonist and rapidly absorbed from gastro intestinal tract but...

  • Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma. Smyth, E.T.; Pavord, I.D.; Wong, C.S.; Wisniewski, A.F.Z.; Williams, J.; Tattersfield, A.E.T. // BMJ: British Medical Journal (International Edition);2/27/93, Vol. 306 Issue 6877, p543 

    Examines the pharmacological interaction of salmeterol and salbutamol on patients with asthma. Effect of adding salbutamol to salmeterol on patients; Potency of salmeterol over salbutamol; Comparison of daily equivalent dosage.

  • Metabolic consequences of salbutamol poisoning reversed by propranolol. Conneli, J.M.C.; Cook, G.M.; McInnes, G.T. // British Medical Journal (Clinical Research Edition);9/18/1982, Vol. 285 Issue 6344, p779 

    Presents a case report on side effects in administration of salbutamol. Occurrence of hypokalemia; Reaction of the patient towards salbutamol; Effects of salbutamol on the homeostasis of plasma nutrients in the body.

  • Nebulised salbutamol and angina. Neville, E.; Corris, P.A.; Vivian, Jene; Nariman, S.; Gibson, G.J. // British Medical Journal (Clinical Research Edition);9/18/1982, Vol. 285 Issue 6344, p796 

    Presents case reports related to nebulizer treatment and angina. Usage of salbutamol as bronchodilator; Cardiac effects of salbutamol; Suggestion on cautious use of salbutamol in nebulizers.

  • Metabolic effects of oral salbutamol.  // British Medical Journal;1/3/1976, Vol. 1 Issue 6000, p22 

    Examines the metabolic effect of oral salbutamol in man. Increase of plasma insulin after salbutamol with a more gradual increase in glucose; Influence of adrenergic mechanisms to insulin secretion; Difference between the metabolic changes of intravenous salbutamol and oral salbutamol.

  • Comparison of intravenous and aerosol salbutamol. Retzel, M.R.; Clark, T.J.E. // British Medical Journal;10/16/1976, Vol. 2 Issue 6041, p919 

    Examines the length of action between aerosol salbutamol and intravenous dose. Analysis of the surface concentration of aerosol salbutamol; Significance of the prolonged bronchodilation by doses of aerosol salbutamol to the bronchial epithelium; Benefits of the aerosol route to ambulant patients.

  • Comparison of intravenous aminophylline and salbutamol in severe asthma. Femi-Pearse, D.; George, W.O.; Ilechukwu, S.T.; Elegbeleye, O.O.; Afonja, A.O. // British Medical Journal;2/19/1977, Vol. 1 Issue 6059, p491 

    Compares the intravenous aminophylline with salbutamol in patients with severe asthma, a common respiratory emergency treated in Great Britain. Dosages of aminophylline and salbutamol; Effectiveness of intravenous salbutamol in treatment of asthma; Characteristics of patients in the study.

  • Intravenous...agonist in severe acute asthma.  // BMJ: British Medical Journal (International Edition);8/13/88, Vol. 297 Issue 6646, p447 

    Examines the effectiveness of salbutamol in treating severe asthma when given intravenously or by inhalation. Comparison between the effectiveness of intravenous salbutamol and nebulized salbutamol; Change in peak expiratory flow rate; Adverse effects of treatment.


Read the Article


Sign out of this library

Other Topics